{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T06:46:21Z","timestamp":1776149181925,"version":"3.50.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":2112,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3,4]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Treatment with helminthes and helminthes ova improved the clinical symptoms of several autoimmune diseases in patients and in animal models. Phosphorylcholine (PC) proved to be the immunomodulatory molecule. We aimed to decipher the tolerogenic potential of tuftsin\u2013PC (TPC), a novel helminth-based compound in collagen-induced arthritis (CIA) a mouse model of rheumatoid arthritis (RA). CIA DBA\/1 mice were treated with TPC subcutaneously (5 \u00b5g\/0.1 ml) or orally (250 \u00b5g\/0.1 ml), starting prior to disease induction. The control groups were treated with PBS. Collagen antibodies were tested by enzyme-linked immunosorbent assay (ELISA), cytokine protein levels by ELISA kits and regulatory T (Treg) and regulatory B (Breg) cell phenotypes by fluorescence-activated cell sorter (FACS). TPC-treated mice had a significantly lower arthritis score of 1.5 in comparison with control mice 11.8 (P\u2009&amp;lt;\u20090.0001) in both subcutaneous and orally treated groups at day 31. Moreover, histology analysis demonstrated highly inflamed joints in control mice, whereas TPC-treated mice maintained normal joint structure. Furthermore, TPC decreased the titres of circulating collagen II antibodies in mice sera (P &amp;lt; 0.0001), enhanced expression of IL-10 (P &amp;lt; 0.0001) and inhibited production of tumour necrosis factor (TNF)-\u03b1, interleukin (IL)\u221217 and IL-1\u03b2 (P &amp;lt; 0.0001). TPC significantly expanded the CD4+CD25+ forkhead box protein 3 (FoxP3+) Treg cells and CD19+IL-10+CD5highCD1dhighT cell immunoglobulin mucin-1 (TIM-1+) Breg cell phenotypes (P &amp;lt; 0.0001) in treated mice. Our data indicate that treatment with TPC attenuates CIA in mice demonstrated by low arthritic score and normal joints histology. TPC treatment reduced proinflammatory cytokines and increased anti-inflammatory cytokine expression, as well as expansion of Treg and Breg cells. Our results may lead to a new approach for a natural therapy for early rheumatoid arthritis onset.<\/jats:p>","DOI":"10.1111\/cei.12745","type":"journal-article","created":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T23:08:48Z","timestamp":1448924928000},"page":"19-28","source":"Crossref","is-referenced-by-count":47,"title":["Novel therapeutic compound tuftsin\u2013phosphorylcholine attenuates collagen-induced arthritis"],"prefix":"10.1093","volume":"184","author":[{"given":"T","family":"Bashi","sequence":"first","affiliation":[{"name":"Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, affiliated to the Sackler Faculty of Medicine Tel-Aviv University, Tel-Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Shovman","sequence":"additional","affiliation":[{"name":"Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, affiliated to the Sackler Faculty of Medicine Tel-Aviv University, Tel-Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Fridkin","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, The Weizmann Institute of Sciences, Rehovot, Israel, Tel-Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Volkov","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Sheba Medical Center, affiliated to the Sackler Faculty of Medicine Tel-Aviv University, Tel-Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Barshack","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Sheba Medical Center, affiliated to the Sackler Faculty of Medicine Tel-Aviv University, Tel-Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Blank","sequence":"additional","affiliation":[{"name":"Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, affiliated to the Sackler Faculty of Medicine Tel-Aviv University, Tel-Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Shoenfeld","sequence":"additional","affiliation":[{"name":"Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, affiliated to the Sackler Faculty of Medicine Tel-Aviv University, Tel-Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,2,4]]},"reference":[{"key":"2021111804092269100_cei12745-bib-0001","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","article-title":"The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study","volume":"73","author":"Cross","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2021111804092269100_cei12745-bib-0002","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.0105-2896.2009.00850.x","article-title":"Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis","volume":"233","author":"Wegner","year":"2010","journal-title":"Immunol Rev"},{"key":"2021111804092269100_cei12745-bib-0003","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"key":"2021111804092269100_cei12745-bib-0004","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa073491","article-title":"TRAF1-C5 as a risk locus for rheumatoid arthritis \u2013 a genomewide study","volume":"357","author":"Plenge","year":"2007","journal-title":"N Engl J Med"},{"key":"2021111804092269100_cei12745-bib-0005","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.autrev.2014.08.026","article-title":"Methotrexate for the treatment of rheumatoid arthritis in the biologic era: still an \u2018anchor\u2019 drug?","volume":"13","author":"Favalli","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2021111804092269100_cei12745-bib-0006","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/art.38949","article-title":"A randomized, double-blind, placebo-controlled, twelve-week, dose-ranging study of decernotinib, an oral selective JAK-3 inhibitor, as monotherapy in patients with active rheumatoid arthritis","volume":"67","author":"Fleischmann","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2021111804092269100_cei12745-bib-0007","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5455\/medarh.2014.68.51-53","article-title":"Treatment of rheumatoid arthritis with biologic DMARDS (Rituximab and Etanercept)","volume":"68","author":"Gashi","year":"2014","journal-title":"Med Arch"},{"key":"2021111804092269100_cei12745-bib-0008","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.3899\/jrheum.130767","article-title":"Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?","volume":"41","author":"Ciubotariu","year":"2014","journal-title":"J Rheumatol"},{"key":"2021111804092269100_cei12745-bib-0009","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1056\/NEJMms1215400","article-title":"Contagious diseases in the United States from 1888 to the present","volume":"369","author":"van Panhuis","year":"2013","journal-title":"N Engl J Med"},{"key":"2021111804092269100_cei12745-bib-0010","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/ard.34.2.136","article-title":"Rheumatoid arthritis in a rural South African Negro population","volume":"34","author":"Beighton","year":"1975","journal-title":"Ann Rheum Dis"},{"key":"2021111804092269100_cei12745-bib-0011","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.coi.2013.02.006","article-title":"Vaccine against autoimmune disease: can helminths or their products provide a therapy?","volume":"25","author":"Zaccone","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"2021111804092269100_cei12745-bib-0012","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nrrheum.2013.3","article-title":"Autoimmunity: will worms cure rheumatoid arthritis?","volume":"9","author":"Shor","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"2021111804092269100_cei12745-bib-0013","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijpara.2008.08.007","article-title":"Schistosoma mansoni infection reduces severity of collagen-induced arthritis via down-regulation of pro-inflammatory mediators","volume":"39","author":"Osada","year":"2009","journal-title":"Int J Parasitol"},{"key":"2021111804092269100_cei12745-bib-0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.molbiopara.2009.04.008","article-title":"Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity","volume":"167","author":"Hewitson","year":"2009","journal-title":"Mol Biochem Parasitol"},{"key":"2021111804092269100_cei12745-bib-0015","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nri2199","article-title":"Protective immune mechanisms in helminth infection","volume":"7","author":"Anthony","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"2021111804092269100_cei12745-bib-0016","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/gut.2004.041749","article-title":"Trichuris suis therapy in Crohn's disease","volume":"54","author":"Summers","year":"2005","journal-title":"Gut"},{"key":"2021111804092269100_cei12745-bib-0017","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.4049\/jimmunol.175.9.5817","article-title":"ES-62, an immunomodulator secreted by filarial nematodes, suppresses clonal expansion and modifies effector function of heterologous antigen-specific T cells in vivo","volume":"175","author":"Marshall","year":"2005","journal-title":"J Immunol"},{"key":"2021111804092269100_cei12745-bib-0018","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2174\/1568026043451212","article-title":"The anti-inflammatory potential of the filarial nematode secreted product, ES-62","volume":"4","author":"Harnett","year":"2004","journal-title":"Curr Top Med Chem"},{"key":"2021111804092269100_cei12745-bib-0019","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1136\/ard.2007.073502","article-title":"The phosphorycholine moiety of the filarial nematode immunomodulator ES-62 is responsible for its anti-inflammatory action in arthritis","volume":"67","author":"Harnett","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2021111804092269100_cei12745-bib-0020","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/187153012799278893","article-title":"Immunomodulatory properties of ES-62, a phosphorylcholine-containing glycoprotein secreted by Acanthocheilonema viteae","volume":"12","author":"Al-Riyami","year":"2012","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"2021111804092269100_cei12745-bib-0021","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1742-4658.2006.05615.x","article-title":"N-glycans of the porcine nematode parasite Ascaris suum are modified with phosphorylcholine and core fucose residues","volume":"274","author":"Poltl","year":"2007","journal-title":"FEBS J"},{"key":"2021111804092269100_cei12745-bib-0022","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/eji.1830040914","article-title":"Phosphorylcholine-bearing components in homogenates of nematodes","volume":"4","author":"Pery","year":"1974","journal-title":"Eur J Immunol"},{"key":"2021111804092269100_cei12745-bib-0023","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0196-9781(99)00019-4","article-title":"Tuftsin: on the 30-year anniversary of Victor Najjar's discovery","volume":"20","author":"Siemion","year":"1999","journal-title":"Peptides"},{"key":"2021111804092269100_cei12745-bib-0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10409238909082550","article-title":"Tuftsin: its chemistry, biology, and clinical potential","volume":"24","author":"Fridkin","year":"1989","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"2021111804092269100_cei12745-bib-0025","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/228672a0","article-title":"Tuftsin\u2019: a natural phagocytosis stimulating peptide","volume":"228","author":"Najjar","year":"1970","journal-title":"Nature"},{"key":"2021111804092269100_cei12745-bib-0026","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jaut.2014.11.001","article-title":"Phosphorylcholine\u2013tuftsin compound prevents development of dextransulfate-sodium-salt induced murine colitis: implications for the treatment of human inflammatory bowel disease","volume":"56","author":"Ben-Ami Shor","year":"2015","journal-title":"J Autoimmun"},{"key":"2021111804092269100_cei12745-bib-0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2015.03.001","article-title":"Successful modulation of murine lupus nephritis with tuftsin\u2013phosphorylcholine","volume":"59","author":"Bashi","year":"2015","journal-title":"J Autoimmun"},{"key":"2021111804092269100_cei12745-bib-0028","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/0006-291X(73)91188-1","article-title":"Production and characterization of an antiserum to synthetic gonadotropin-releasing hormone","volume":"55","author":"Koch","year":"1973","journal-title":"Biochem Biophys Res Commun"},{"key":"2021111804092269100_cei12745-bib-0029","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nprot.2007.173","article-title":"Collagen-induced arthritis","volume":"2","author":"Brand","year":"2007","journal-title":"Nat Protoc"},{"issue":"Suppl. 5","key":"2021111804092269100_cei12745-bib-0030","doi-asserted-by":"crossref","first-page":"v3","DOI":"10.1093\/rheumatology\/kes113","article-title":"Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis","volume":"51","author":"Choy","year":"2012","journal-title":"Rheumatology"},{"key":"2021111804092269100_cei12745-bib-0031","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"2021111804092269100_cei12745-bib-0032","first-page":"391","article-title":"The influence of the nematode Syphacia oblevata on adjuvant arthritis in the rat","volume":"29","author":"Pearson","year":"1975","journal-title":"Immunology"},{"key":"2021111804092269100_cei12745-bib-0033","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/art.38392","article-title":"ES-62 protects against collagen-induced arthritis by resetting interleukin-22 toward resolution of inflammation in the joints","volume":"66","author":"Pineda","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2021111804092269100_cei12745-bib-0034","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.4049\/jimmunol.171.4.2127","article-title":"A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62","volume":"171","author":"McInnes","year":"2003","journal-title":"J Immunol"},{"key":"2021111804092269100_cei12745-bib-0035","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.ijpara.2014.05.001","article-title":"Small molecule analogues of the immunomodulatory parasitic helminth product ES-62 have anti-allergy properties","volume":"44","author":"Rzepecka","year":"2014","journal-title":"Int J Parasitol"},{"key":"2021111804092269100_cei12745-bib-0036","doi-asserted-by":"crossref","first-page":"9982","DOI":"10.1021\/jm401251p","article-title":"Designing anti-inflammatory drugs from parasitic worms: a synthetic small molecule analogue of the Acanthocheilonema viteae product ES-62 prevents development of collagen-induced arthritis","volume":"56","author":"Al-Riyami","year":"2013","journal-title":"J Med Chem"},{"key":"2021111804092269100_cei12745-bib-0037","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4049\/jimmunol.174.1.284","article-title":"Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62","volume":"174","author":"Goodridge","year":"2005","journal-title":"J Immunol"},{"key":"2021111804092269100_cei12745-bib-0038","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-3024.2006.00926.x","article-title":"Phosphorylcholine mimics the effects of ES-62 on macrophages and dendritic cells","volume":"29","author":"Goodridge","year":"2007","journal-title":"Parasite Immunol"},{"key":"2021111804092269100_cei12745-bib-0039","doi-asserted-by":"crossref","first-page":"e34933","DOI":"10.1371\/journal.pone.0034933","article-title":"Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis","volume":"7","author":"Wu","year":"2012","journal-title":"PLOS ONE"},{"key":"2021111804092269100_cei12745-bib-0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2249.2009.04016.x","article-title":"The role of T helper type 17 cells in inflammatory arthritis","volume":"159","author":"Sarkar","year":"2010","journal-title":"Clin Exp Immunol"},{"key":"2021111804092269100_cei12745-bib-0041","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.4049\/jimmunol.167.8.4710","article-title":"T cell activation in rheumatoid synovium is B cell dependent","volume":"167","author":"Takemura","year":"2001","journal-title":"J Immunol"},{"key":"2021111804092269100_cei12745-bib-0042","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12016-012-8318-y","article-title":"To B or not to B the conductor of rheumatoid arthritis orchestra","volume":"43","author":"Moura","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"2021111804092269100_cei12745-bib-0043","doi-asserted-by":"crossref","first-page":"173ra23","DOI":"10.1126\/scitranslmed.3005407","article-title":"CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation","volume":"5","author":"Flores-Borja","year":"2013","journal-title":"Sci Transl Med"},{"key":"2021111804092269100_cei12745-bib-0044","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nature11501","article-title":"Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions","volume":"491","author":"Yoshizaki","year":"2012","journal-title":"Nature"},{"key":"2021111804092269100_cei12745-bib-0045","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-065X.2008.00646.x","article-title":"B lymphocyte contributions to human autoimmune disease","volume":"223","author":"Yanaba","year":"2008","journal-title":"Immunol Rev"},{"key":"2021111804092269100_cei12745-bib-0046","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1749-6632.2009.05137.x","article-title":"B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer","volume":"1183","author":"DiLillo","year":"2010","journal-title":"Ann NY Acad Sci"},{"key":"2021111804092269100_cei12745-bib-0047","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","article-title":"A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses","volume":"28","author":"Yanaba","year":"2008","journal-title":"Immunity"},{"key":"2021111804092269100_cei12745-bib-0048","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1172\/JCI46274","article-title":"Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice","volume":"121","author":"Ding","year":"2011","journal-title":"J Clin Invest"},{"key":"2021111804092269100_cei12745-bib-0049","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.4049\/jimmunol.1103354","article-title":"A novel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand","volume":"188","author":"Ray","year":"2012","journal-title":"J Immunol"},{"key":"2021111804092269100_cei12745-bib-0050","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.4049\/jimmunol.178.6.3447","article-title":"B cell regulation of CD4+CD25+ T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis","volume":"178","author":"Mann","year":"2007","journal-title":"J Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12745","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/184\/1\/19\/41126332\/cei12745.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/184\/1\/19\/41126332\/cei12745.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:26:56Z","timestamp":1641054416000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/184\/1\/19\/6412172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,4]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,2,4]]},"published-print":{"date-parts":[[2016,3,4]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12745","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,4]]},"published":{"date-parts":[[2016,2,4]]}}}